Respiratory Syncytial Virus Vaccines for the Prevention of Lower Respiratory Tract Infections in Patients Living with Chronic Obstructive Pulmonary Disease: A Rapid Review

Background: Patients living with chronic obstructive pulmonary disease (COPD) are at risk for lower respiratory tract infections caused by respiratory syncytial virus (RSV). The first RSV vaccines were approved in 2023 for adults ages 60 years and older. The safety and efficacy of the RSV vaccines a...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Paul M. Boylan, Megan E. Fleischman, Nathan Pinner, Joseph Andrew Woods, Adam Welch
Format:	Artigo
Sprog:	Inglês
Udgivet:	MDPI AG 2024-01-01
Serier:	Biologics
Fag:	respiratory syncytial virus vaccines respiratory syncytial virus respiratory tract infections chronic obstructive pulmonary disease
Online adgang:	https://www.mdpi.com/2673-8449/4/1/2
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!